Portfolio company
Isomorphic Labs
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
About
This company develops artificial intelligence platforms for drug discovery and design to serve pharmaceutical and biotechnology businesses.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Insilico Medicine
This company develops artificial intelligence platforms for drug discovery and design to serve pharmaceutical and biotechnology organisations.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Chai Discovery
This company develops artificial intelligence models to predict and design molecular structures and protein binders for pharmaceutical and life sciences researchers.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Capsule AI
This company develops autonomous agent systems that conduct scientific research and strategic analysis for pharmaceutical and biotechnology organisations.
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
310.ai
This company develops generative artificial intelligence models to design novel proteins and biomolecules for pharmaceutical and biotechnology organisations.
DreamFold AI
This company develops generative artificial intelligence models for protein design to discover medicines for pharmaceutical and biotechnology researchers.